Does immune activation continue during an attack-free period in familial Mediterranean fever?

Clinical and Experimental Immunology

Volumn 138, Issue 3, 2004, Pages 526-533

  Musabak, U ^a   Sengul, A ^a   Oktenli, Cagatay ^a   Pay, S ^a   Yesilova, Z ^a   Kenar, L ^a   Sanisoglu, S Y ^a   Inal, A ^a   Tuzun, A ^a   Erdil, A ^a   Bagci, S ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Familial Mediterranean fever; IL 10; Lymphocyte culture; sIL 2R; T cell activity

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; FIBRINOGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; PHYTOHEMAGGLUTININ;

ABDOMINAL PAIN; ARTHRALGIA; ARTHRITIS; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL LYMPHOCYTE; PLEURISY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS;

EID: 9644260350     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02632.x     Document Type: Article

References (30)

1. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351:659-64.
2. Orbach H, Ben-Chetrit E. Familial Mediterranean fever. Minerva Med 2001; 92:421-30.
3. Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61:79-81.
4. Centola M, Wood G, Frucht DM et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95:3223-31.
5. Gang N, Drenth JP, Langevitz P et al. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 1999; 26:890-7.
6. Karagezian KG, Nazaretian EE, Zavgorodniaia AM, Ovnanian KO. Immune disorders in periodic disease. Klin Med 2000; 78:24-5.
7. Melamed A, Cabili S, Zakuth V, Spirer Z. The immune regulation in familial Mediterranean fever. J Clin Lab Immunol 1988; 26:125-8.
8. Schattner A, Lachmi M, Livneh A, Pras M, Hahn T. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1991; 90:434-8.
9. Ozyilkan E, Simsek H, Telatar H. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1992; 92:579-80.
10. Rozenbaum M, Katz R, Rozner I, Pollack S. Decreased interleukin-1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 1992; 19:416-8.
11. Akcan Y, Bayraktar Y, Arslan S, Van Thiel DH, Zerrin BC, Yildiz O. The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever. Eur J Med Res 2003; 8:304-6.
12. Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 2003; 22:99-101.
13. Erken E, Gunesacar R, Ozbek S, Konca K. Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 1996; 55:852-5.
14. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40:1879-85.
15. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335:1078-80.
16. Dawson B, Trapp RG. Basic and clinical biostatistics. Singapore: Mc-Graw Hill, 2001.
17. Aypar E, Ozen S, Okur H, Kutluk T, Besbas N, Bakkaloglu A. Th1 polarization in familial Mediterranean fever. J Rheumatol 2003; 30:2011-3.
18. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol 2000; 18:423-49.
19. Saito I. Structure of IL-10 and its role in autoimmune exocrinopathy. Crit Rev Immunol 2000; 20:153-65.
20. Conti P, Kempuraj D, Kandere K et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003; 86:123-9.
21. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003; 55:241-69.
22. Corinti S, Albanesi C, Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001; 166:4312-8.
23. Prakken BJ, Wendling U, van der Zee R, Rutten VPMG, Kuis W, van Eden W. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol 2001; 167:4147-53.
24. Lang R, Rutschman RL, Greaves DR, Murray PJ. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J Immunol 2002; 168:3402-11.
25. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. The dual role of IL-10. Trends Immunol 2003; 24:36-43.
26. Kara T, Jung LKL, Bjorndahl JM, Fu SM. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA-1) by 12-o-tetraconoyl phorbol-13-acetate, mitogens, and antigens. J Exp Med 1986; 164:1988-2005.
27. ++) and stimulation of protein kinase C. J Immunol 1989; 142:1854-60.
28. Schattner A, Gurevitz A, Zemer D, Hahn T. Induced TNF production in vitro as a test for familial Mediterranean fever. Q J Med 1996; 89:205-10.
29. Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H. Serum soluble intercellular adhesion molecule-1 and interleukin-8 levels in familial Mediterranean fever. J Rheumatol 1999; 26:1983-6.
30. Kiraz S, Ertenli I, Arici M et al. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 1998; 16:721-4.